Status:
WITHDRAWN
Measurement of Blood Volume Loss During Burn Surgery
Lead Sponsor:
Virginia Commonwealth University
Collaborating Sponsors:
Daxor Corporation
Conditions:
Surgical Blood Loss
Burns
Eligibility:
All Genders
18-70 years
Brief Summary
Burn surgery is associated with significant reductions in hematocrit. However, it is unclear whether these reductions are the result of hemodilution from non-red cell containing intraoperative transfu...
Detailed Description
Burn surgery is associated with significant changes (reductions) in hematocrit. However, it is unclear whether these reductions are the result of hemodilution from non-red cell containing intraoperati...
Eligibility Criteria
Inclusion
- Sustained thermal burn of a depth that is deep partial thickness to full thickness and requires operative management
- Burn excision must occur within one week of thermal injury
- Burn size between 10-50% of total body surface area
- Must survive initial resuscitation
- Must consent for blood product transfusion
- Male or non-pregnant female
Exclusion
- Cause of burn other than thermal injury (ie electrical or chemical injury)
- Women who are nursing, pregnant, or think they may be pregnant
- Patients with recognized coagulopathy
Key Trial Info
Start Date :
January 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2021
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03340116
Start Date
January 1 2020
End Date
January 1 2021
Last Update
October 15 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.